Davis AE, Brogan AJ, Goodwin B, Nocea G, Lozano V. Short-term cost and efficiency analysis of raltegravir versus atazanavir/ritonavir or darunavir/ritonavir for treatment-naive adults with HIV-1 infection in Spain. HIV Clin Trials. 2017 Nov;18(5-6):214-22. doi: 10.1080/15284336.2017.1402144
Moran D, Juliao P, Alvarez D, Lindblade KA, Ellison JA, Gilbert AT, Petersen B, Rupprecht C, Recuenco S. Knowledge, attitudes and practicesregarding rabies and exposure to bats in two rural communities in Guatemala. BMC Res Notes. 2015 Jan 10;8:955. doi: 10.1186/s13104-014-0955-1
Sabate M, Pacheco JF, Ballarín E, Ferrer P, Petri H, Hasford J, Schoonen MW, Rottenkolber M, Fortuny J, Laporte JR, Ibanez L. A compilation of research working groups on drug utilisation across Europe. BMC Res Notes. 2014;7:143.
Viera AJ, Edwards T. Does an offer for a free on-line continuing medical education (CME) activity increase physician survey response rate? A randomized trial. BMC Res Notes. 2012 Mar 7;5:129. doi: 10.1186/1756-0500-5-129
Soler-Gonzalez J, Ruiz C, Serna C, Marsal JR. The profile of general practitioners (GPs) who publish in selected family practice journals. BMC Res Notes. 2011 May 26;4:164. doi: 10.1186/1756-0500-4-164
Brogan AJ, Mrus J, Hill A, Sawyer AW, Smets E. Comparative cost-efficacy analysis of darunavir/ritonavir and other ritonavir-boosted protease inhibitors for first-line treatment of HIV-1 infection in the United States. HIV Clin Trials. 2010 May;11(3):133-44.